Office of New Drug II, Pharmaceuticals and Medical Devices Agency
2024 Volume 55 Issue 5 Pages 334-339
(compatible with EndNote, Reference Manager, ProCite, RefWorks)
(compatible with BibDesk, LaTeX)
Already have an account? Sign in here
